About us

As you know "KYMOS is your reliable partner for research and development". This is our Leitmotif, but it is not only a nice sentence, it contains our Mission as a company. Our will is to be considered as a PARTNER instead of a service provider since this status presupposes to be part of the projects in which we are involved and to share the goals of the companies to whom we work for.

KYMOS was founded in 2001 by a group of  professionals with more than 10 years of experience in research and development areas of pharmaceutical industries. The staff members were clients before being suppliers achieving a deep knowledge of the pharma company requirements and priorities that allowed a fast start-up.

We are a highly qualified team of chemistry and pharmacy PhDs and graduates, who have been responsible for key research and quality control departments within the pharmaceutical sector. We understand our clients’ concerns far beyond the service given to them as we have gone through similar professional situations and we speak the same language. To join our team Click Here.

The studies performed by KYMOS are conducted under the internationally accepted quality standards, following the guidelines issued by ICH, EMA, FDA and other relevant Health Authorities. Kymos is under EMA regulatory domain and it is periodically inspected by the Spanish Medicines Agency (AEMPS). In July 2017 Kymos has been inspected by the FDA.

We are located at an amazing venue at the foothill of Collserola Park, Barcelona's "green lung". Sharing a scientific environment with the Autonomous University of Barcelona, the Syncrothon Alba and a lot of biopharmaceutical companies at walking distance. We benefit from two stand alone building of 1,500 m2 for labs and 1,000 m2 for offices.

We are affording huge investments in the last years in order to offer you the state of the art technology. All our equipent, instruments and software are properly validated and qualified according to applicable regulations with appropriated maintenance contracts and most of them have an internal back-up.

Research, Development & Innovation (R+D+I) is essential in all industries, but in the Biopharmaceutical industry it is still more important. The evolution of science is so fast and the new discoveries are so disruptive that all players of the value chain involved in research should rise to the challenge.

KYMOS believes that the best way to work in a very competitive and specialized environment is collaboration. Beyond multiple cooperations with different companies Kymos is proud to be a reputted member of EuroPharmaBridge, a one-stop-shop for European market access, and Vivalliance, a cluster of preclinical CROs.

KYMOS has a strong and direct presence in Spain, Portugal, France, Italy, Switzerland and Germany. In these countries we count with local business development managers monitoring the market and being in constant contact with our clients to provide them the best possible support and a counterpart in their mother tongue. Other markets in Asia (China, India, South Korea and Japan), Nordic European countries and United States are also important for KYMOS.

We place at your disposal our availbale catalogs to give you a more detailed view about the extension of our services. You can download the catalogs in .pdf format. Do not hesitate to ask us for printed versions if you need them.